Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Get Quote
Search InvestCenter
Recent Quotes
Armstrong World Industries Inc Common Stock
Intellia Therapeutics, Inc. - Common Stock
LifeMD, Inc. - Common Stock
Upstart Holdings, Inc. - Common stock
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Intellia Therapeutics, Inc. - Common Stock
(NQ:
NTLA
)
10.64
-0.09 (-0.84%)
Streaming Delayed Price
Updated: 10:46 AM EDT, Jul 3, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Intellia Therapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
18
19
Next >
FDA Halts Trials Exporting Americans' Cells To Hostile Countries For Genetic Engineering
June 20, 2025
FDA launches review of trials that sent American DNA to China without full consent; NIH investigates impact of Biden-era exemption on federally funded research
Via
Benzinga
Eli Lilly's $1.3 Billion Verve Deal Signals Confidence In Gene Editing Space: Analyst
June 18, 2025
Lilly's Verve acquisition lifts sentiment in gene editing stocks, with analysts calling it a strategic and timely move in a tough funding climate.
Via
Benzinga
Jabil Posts Upbeat Earnings, Joins Verve Therapeutics, John Wiley & Sons And Other Big Stocks Moving Higher On Tuesday
June 17, 2025
Via
Benzinga
Verve Therapeutics Skyrockets — Pulling Gene-Editing Stocks Higher — On $1.3 Billion Eli Lilly Takeover
June 17, 2025
The companies were already collaborating on a handful of cardiovascular-focused gene-editing treatments.
Via
Investor's Business Daily
Demystifying Intellia Therapeutics: Insights From 9 Analyst Reviews
May 29, 2025
Via
Benzinga
Earnings Scheduled For May 8, 2025
May 08, 2025
Via
Benzinga
A Glimpse of Intellia Therapeutics's Earnings Potential
May 07, 2025
Via
Benzinga
Assessing Intellia Therapeutics: Insights From 9 Financial Analysts
June 16, 2025
Via
Benzinga
Cathie Wood's Ark Invest Continues To Offload Tesla As Elon Musk Moves On From Trump Administration
May 30, 2025
Ark Invest made significant trades in TSLA, TXG, NTLA, DDD, and ADPT. Purchase of TXG and NTLA from ARKG and ARKK funds, and sale of TSLA, DDD, and ADPT from various funds.
Via
Benzinga
Topics
Government
12 Health Care Stocks Moving In Thursday's Intraday Session
May 29, 2025
Via
Benzinga
Keep an eye on the top gainers and losers in Thursday's session.
May 29, 2025
Looking for insights into the US markets in the middle of the day on Thursday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Via
Chartmill
Intellia Therapeutics Stock Plummets After Adverse Event In Gene Editing Therapy Study: But Retail’s Buying The Dip
May 29, 2025
The patient’s elevated levels of liver enzymes appear to be resolving without hospitalization or medical intervention, the company said.
Via
Stocktwits
Intellia Therapeutics' Rare Heart Disease Candidate Reports Liver Enzyme Spike In Phase 3 Trial, But Stays On Course
May 29, 2025
Intellia reports a grade 4 liver enzyme elevation in a Nex-Z trial patient; no hospitalization is required, and enrollment remains on track across programs.
Via
Benzinga
The market is filled with gapping stocks in Thursday's session.
May 29, 2025
Today's session on Thursday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.
Via
Chartmill
HP Posts Downbeat Earnings, Joins SentinelOne, Best Buy And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
May 29, 2025
Via
Benzinga
What's going on in today's pre-market session
May 29, 2025
Before the US market kicks off on Thursday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.
Via
Chartmill
12 Health Care Stocks Moving In Thursday's Pre-Market Session
May 29, 2025
Via
Benzinga
Why Nvidia Shares Are Trading Higher By Over 5%; Here Are 20 Stocks Moving Premarket
May 29, 2025
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
May 28, 2025
Via
Benzinga
Analysts Think These Stocks Could More Than Double in Value
May 23, 2025
Septerna, Intellia, and Novavax have garnered investor attention for their significant upside potential, but investors should beware the risks as well.
Via
MarketBeat
Topics
World Trade
INTELLIA ALERT: Bragar Eagel & Squire, P.C. is Investigating Intellia Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
May 22, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
Forecasting The Future: 11 Analyst Projections For Intellia Therapeutics
May 12, 2025
Via
Benzinga
Marriott International To Rally More Than 17%? Here Are 10 Top Analyst Forecasts For Monday
May 12, 2025
Via
Benzinga
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
April 30, 2025
The popular growth investor keeps adding to some of her favorite stocks.
Via
The Motley Fool
Topics
Artificial Intelligence
World Trade
Cathie Wood's Ark Invest Loads Up On Intellia Therapeutics, Offloads Meta Platforms
April 26, 2025
ARK Invest made significant trades in NTLA, META, VCYT, SYM, BIDU, and PATH. These moves come amidst changes in stock prices. Read more for full details.
Via
Benzinga
Why Sarepta Therapeutics And Other Genetics Stocks Just Got A Sizable Boost
April 21, 2025
The new FDA commissioner had a few key ideas for the agency in an interview with Megyn Kelly.
Via
Investor's Business Daily
Topics
Government
Wolverine World Wide, Pacira BioSciences And Other Big Stocks Moving Higher On Monday
April 21, 2025
Via
Benzinga
NTLA Investors Have Opportunity to Lead Intellia Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
April 14, 2025
From
The Schall Law Firm
Via
Business Wire
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Intellia Therapeutics
April 14, 2025
From
Faruqi & Faruqi, LLP
Via
Business Wire
NTLA Investors Have the Opportunity to Lead the Intellia Therapeutics Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
April 13, 2025
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
...
18
19
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.